Evidence map›Paper›PMID 40422572›Full record

ArticleDiseases (Basel, Switzerland)2025

Labdane Diterpenoids from

Jane Busisiwe Ncongwane, Comfort Mduduzi Nkambule, Gerda Fouche, Douglas Kemboi, Nyeleti Vukea, Candace Davison, Jo-Anne de la Mare, Vuyelwa Jacqueline Tembu

Erratum issuedAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Diseases (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Correction: Ncongwane et al. Labdane Diterpenoids fromDiseases (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors.

Jane Busisiwe NcongwaneDepartment of Chemistry, Tshwane University of Technology, Private Bag X680, Pretoria 0001, South Africa.
Comfort Mduduzi NkambuleDepartment of Chemistry, Tshwane University of Technology, Private Bag X680, Pretoria 0001, South Africa.ORCID 0000-0002-5232-1514
Gerda FoucheDepartment of Chemistry, University of Pretoria, Pretoria 0001, South Africa.
Douglas KemboiDepartment of Chemistry, Tshwane University of Technology, Private Bag X680, Pretoria 0001, South Africa.ORCID 0000-0003-3771-128X
Nyeleti VukeaDepartment of Biochemistry and Microbiology, Rhodes University, Grahamstown 6140, South Africa.
Candace DavisonDepartment of Biochemistry and Microbiology, Rhodes University, Grahamstown 6140, South Africa.
Jo-Anne de la MareDepartment of Biochemistry and Microbiology, Rhodes University, Grahamstown 6140, South Africa.
Vuyelwa Jacqueline TembuDepartment of Chemistry, Tshwane University of Technology, Private Bag X680, Pretoria 0001, South Africa.

Funding

NRF SOUTH AFRICA TK190403426633
6 · The paper itself

Abstract

backgroundTriple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer with limited therapeutic options.

methodsCompounds from

resultsA previously unreported

conclusionsThe findings from this study warrant further investigation of

Indexed as

bis-spirolabdanebreast cancercytotoxic activityHCC70labdane diterpenoidsLeonotisLeonotis ocymifoliaMCF-7

Identifiers

PMID40422572
PMCPMC12110735

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.